pre‑funded warrants

  • KALA BIO Completes $10 Million At-The-Market Direct Offering of Common Stock Under Nasdaq Rules Markets

    KALA BIO Completes $10 Million At-The-Market Direct Offering of Common Stock Under Nasdaq Rules

    KALA BIO (NASDAQ:KALA) completed a registered direct offering on Dec 5 2025, selling 10 million common shares (or pre‑funded warrants) at $1.00 each, generating roughly $10 million in gross proceeds. H.C. Wainwright acted as exclusive placement agent. Net proceeds will be used to repay indebtedness and for general corporate purposes. The offering was executed under a shelf registration (File No. 333‑270263) filed Mar 3 2023 and became effective May 11 2023.

    9 hours ago